Cosmo Bio Co (TSE:3386) Scaled Net Operating Assets: 0.60 (As of Dec. 2025)

Cosmo Bio Co TSE:3386 -0.55% 73 Scaled Net Operating Assets is 0.60 as of Dec. 2025. GuruFocus rates TSE:3386 with a GF Score™ of 73/100 and a GF Value™ of 円1,246.90 (Fairly Valued). The stock has 4 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Cosmo Bio Co's operating assets for the quarter that ended in Dec. 2025 was 円9,716 Mil. Cosmo Bio Co's operating liabilities for the quarter that ended in Dec. 2025 was 円2,687 Mil. Cosmo Bio Co's Total Assets for the quarter that ended in Jun. 2025 was 円11,790 Mil. Therefore, Cosmo Bio Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2025 was 0.60.

Cosmo Bio Co Scaled Net Operating Assets Related Terms

Cosmo Bio Co Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Cosmo Bio Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo Bio Co Scaled Net Operating Assets Chart

Cosmo Bio Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.50

0.56

0.58

0.63

0.60

Cosmo Bio Co Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.56	0.61	0.59	0.56	0.60

TSE:3386 vs TMO, DHR, IDXX: Scaled Net Operating Assets Comparison

For the Diagnostics & Research subindustry, Cosmo Bio Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cosmo Bio Co Scaled Net Operating Assets vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cosmo Bio Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Cosmo Bio Co's Scaled Net Operating Assets falls into.

Save Embed

73GF Score

Cosmo Bio Co Ltd TSE:3386

Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cosmo Bio Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Cosmo Bio Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2025 )
=	(Operating Assets (A: Dec. 2025 )	-	Operating Liabilities (A: Dec. 2025 ))	/	Total Assets (A: Dec. 2024 )
=	(9716	-	2687)	/	11723
=	0.60

where

	Operating Assets		(A: Dec. 2025 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	12662	-	2946
=	9716

	Operating Liabilities		(A: Dec. 2025 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2707	-	0	-	20
=	2687

Cosmo Bio Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2025 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2025 )
=	(Operating Assets (Q: Dec. 2025 )	-	Operating Liabilities (Q: Dec. 2025 ))	/	Total Assets (Q: Jun. 2025 )
=	(9716	-	2687)	/	11790
=	0.60

where

	Operating Assets		(Q: Dec. 2025 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	12662	-	2946
=	9716

	Operating Liabilities		(Q: Dec. 2025 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2707	-	0	-	20
=	2687

Frequently Asked Questions Learn more about Scaled Net Operating Assets →

What does a Scaled Net Operating Assets of 0.60 mean?

Cosmo Bio Co (TSE:3386) has a Scaled Net Operating Assets of 0.60 as of Dec. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Cosmo Bio Co and its competitors.

Is Cosmo Bio Co's Scaled Net Operating Assets too high?

Cosmo Bio Co's current Scaled Net Operating Assets is 0.60. Overall, Cosmo Bio Co has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Cosmo Bio Co's Scaled Net Operating Assets compare to TMO and DHR?

Cosmo Bio Co's Scaled Net Operating Assets of 0.60 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Scaled Net Operating Assets for a Medical Diagnostics & Research company?

A good Scaled Net Operating Assets depends on the Medical Diagnostics & Research industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Scaled Net Operating Assets mean?

A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Cosmo Bio Co and its competitors. Cosmo Bio Co's current Scaled Net Operating Assets is 0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cosmo Bio Co stock overvalued right now?

Based on GuruFocus' analysis, Cosmo Bio Co (TSE:3386) is currently considered Fairly Valued. The stock's GF Value™ is 円1,246.90, compared to a current price of 円1,262.00 — trading 1.2% above its estimated fair value. The current Scaled Net Operating Assets is 0.60. Cosmo Bio Co's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Scaled Net Operating Assets calculated?

Scaled Net Operating Assets is calculated from a company's financial statements. For Cosmo Bio Co (TSE:3386), the current Scaled Net Operating Assets is 0.60 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmo Bio Co (TSE:3386) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo Bio Co stock appears to be overvalued. The current stock price of 円1,262.00 is trading 1.2% above its estimated GF Value™ of 円1,246.90. GuruFocus considers Cosmo Bio Co to be Fairly Valued.

Key valuation signals for TSE:3386:

Scaled Net Operating Assets: 0.60
GF Value™: 円1,246.90 vs. price of 円1,262.00 (1.2% above fair value)
GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the TSE:3386 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmo Bio Co Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies TSE:6090 TSE:4671 TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN MTD DGX LH GH MEDP XPAR:ERF ICLR RVTY

Address 2-20, Toyo-Ekimae Building, Toyo 2-Chome, Koto-ku, Tokyo, JPN, 135-0016

Website http://www.cosmobio.co.jp

Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes the purchase of reagents, instruments, and clinical test drugs for research in life science and domestic sales.

73GF Score

Get the complete analysis for TSE:3386

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,262.00

Price

円1,246.90

GF Value

View TSE:3386 Analysis

See Scaled Net Operating Assets data for all stocks →